Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Germany's Lufthansa enters race for stake in Portuguese airline TAP - 2Senegal limits foreign trips for officials as the fallout from Iran war deepens
- 3Monetary Freedom Guide: Plan Your Future
- 4Investigating the Medical advantages of Aloe Vera
- 5New materials, old physics – the science behind how your winter jacket keeps you warm
- Surveys of Thrillers That Re-imagined the Class
- Mom finds out she has cancer after noticing something was off while breastfeeding
- Top German court to rule on claims by Wirecard shareholders
- Hundreds of Intact Dinosaur Eggs Emerge From 72-Million-Year Time Capsule
- ‘Extraordinary’ Iron Age war trumpet uncovered in England
- Israeli naval intelligence reduces Iranian threat to Strait of Hormuz
- Progress Over Perfection: Lessons From Garment Factories Fighting Heat Stress
- German diesel hits new records over Easter weekend
- Pick Your Favored method of transportation
